Ken Griffin
TEVA icon

Ken Griffin’s Teva Pharmaceuticals TEVA Stock Holding History

Ken Griffin’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,847,855
Closed -$124M – 14215
2025
Q4 		$120M Buy
3,847,855
+2,613,700
+212% +$64.4M 0.02% 751
2025
Q3 		$24.9M Sell
1,234,155
-978,931
-44% -$17.2M ﹤0.01% 2059
2025
Q2 		$37.1M Sell
2,213,086
-640,005
-22% -$10.3M 0.01% 1488
2025
Q1 		$43.9M Buy
2,853,091
+467,669
+20% +$8.35M 0.01% 1254
2024
Q4 		$52.6M Sell
2,385,422
-1,083,040
-31% -$19.7M 0.01% 1225
2024
Q3 		$62.5M Buy
3,468,462
+1,700,049
+96% +$29.8M 0.01% 1028
2024
Q2 		$28.7M Sell
1,768,413
-3,341,713
-65% -$51.5M 0.01% 1643
2024
Q1 		$72.1M Sell
5,110,126
-6,493,437
-56% -$81.9M 0.01% 946
2023
Q4 		$121M Buy
11,603,563
+8,573,014
+283% +$80M 0.02% 579
2023
Q3 		$30.9M Sell
3,030,549
-1,455,496
-32% -$13.6M 0.01% 1475
2023
Q2 		$33.8M Sell
4,486,045
-5,065,306
-53% -$41.1M 0.01% 1382
2023
Q1 		$84.5M Buy
9,551,351
+6,879,779
+258% +$68M 0.02% 714
2022
Q4 		$24.4M Buy
2,671,572
+144,815
+6% +$1.26M 0.01% 1753
2022
Q3 		$20.4M Sell
2,526,757
-7,119,914
-74% -$63M ﹤0.01% 1857
2022
Q2 		$72.5M Buy
9,646,671
+7,778,203
+416% +$67.8M 0.02% 772
2022
Q1 		$17.5M Sell
1,868,468
-505,182
-21% -$4.22M ﹤0.01% 2130
2021
Q4 		$19M Sell
2,373,650
-574,697
-19% -$5.19M ﹤0.01% 2085
2021
Q3 		$28.7M Sell
2,948,347
-89,390
-3% -$837K 0.01% 1607
2021
Q2 		$30.1M Buy
3,037,737
+1,084,671
+56% +$11.5M 0.01% 1611
2021
Q1 		$22.5M Buy
1,953,066
+578,445
+42% +$6.63M 0.01% 1807
2020
Q4 		$13.3M Sell
1,374,621
-882,701
-39% -$8.46M ﹤0.01% 2275
2020
Q3 		$20.3M Buy
2,257,322
+2,005,712
+797% +$21.2M 0.01% 1548
2020
Q2 		$3.1M Sell
251,610
-802,124
-76% -$9.07M ﹤0.01% 3810
2020
Q1 		$9.46M Sell
1,053,734
-1,198,779
-53% -$12.3M ﹤0.01% 1913
2019
Q4 		$22.1M Buy
2,252,513
+1,734,238
+335% +$15.5M 0.01% 1388
2019
Q3 		$3.57M Sell
518,275
-628,822
-55% -$4.82M ﹤0.01% 3584
2019
Q2 		$10.6M Sell
1,147,097
-592,724
-34% -$7.15M ﹤0.01% 2109
2019
Q1 		$27.3M Sell
1,739,821
-680,415
-28% -$12M 0.01% 1086
2018
Q4 		$37.3M Sell
2,420,236
-274,342
-10% -$5.62M 0.02% 787
2018
Q3 		$58M Buy
2,694,578
+1,156,121
+75% +$26.8M 0.03% 674
2018
Q2 		$37.4M Buy
1,538,457
+1,175,143
+323% +$24M 0.02% 868
2018
Q1 		$6.21M Buy
363,314
+106,321
+41% +$2.08M ﹤0.01% 2222
2017
Q4 		$4.87M Sell
256,993
-248,172
-49% -$3.73M ﹤0.01% 2511
2017
Q3 		$8.89M Buy
505,165
+335,878
+198% +$7.56M 0.01% 1707
2017
Q2 		$5.62M Sell
169,287
-444,783
-72% -$13.8M ﹤0.01% 2000
2017
Q1 		$19.7M Sell
614,070
-1,283,377
-68% -$43.8M 0.02% 960
2016
Q4 		$68.8M Buy
1,897,447
+883,698
+87% +$35.3M 0.07% 272
2016
Q3 		$46.6M Buy
1,013,749
+908,663
+865% +$47.4M 0.05% 415
2016
Q2 		$5.28M Sell
105,086
-166,874
-61% -$8.88M 0.01% 1775
2016
Q1 		$14.6M Sell
271,960
-354,961
-57% -$20.8M 0.02% 939
2015
Q4 		$41.2M Buy
626,921
+609,286
+3,455% +$37.7M 0.04% 479
2015
Q3 		$996K Sell
17,635
-783,554
-98% -$50.8M ﹤0.01% 3824
2015
Q2 		$47.4M Buy
801,189
+406,929
+103% +$25.1M 0.04% 525
2015
Q1 		$24.6M Buy
394,260
+178,456
+83% +$10.4M 0.02% 863
2014
Q4 		$12.4M Sell
215,804
-1,052,260
-83% -$58.6M 0.01% 1251
2014
Q3 		$68.2M Sell
1,268,064
-624,387
-33% -$33.1M 0.07% 296
2014
Q2 		$99.2M Buy
1,892,451
+1,598,938
+545% +$81.7M 0.11% 171
2014
Q1 		$15.5M Buy
293,513
+63,921
+28% +$2.95M 0.02% 990
2013
Q4 		$9.2M Sell
229,592
-34,673
-13% -$1.37M 0.01% 1256
2013
Q3 		$9.98M Sell
264,265
-194,404
-42% -$7.58M 0.02% 1102
2013
Q2 		$18M Buy
+458,669
New +$17.9M 0.03% 714

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ken Griffin's TEVA Position: Q1 2026 in Review

Ken Griffin sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 3,847,855 shares — an estimated $124M sold.

Ken Griffin first reported a position in TEVA in Q2 2013 and held it in 51 quarters. The position peaked at $121M in Q4 2023. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Ken Griffin reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 3,847,855 Teva Pharmaceuticals shares in Q1 2026, an estimated $124M.
  • Ken Griffin first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 51 quarters.
  • Ken Griffin's Teva Pharmaceuticals position peaked at $121M in Q4 2023.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.